Cancer Biotherapy & Radiopharmaceuticals, 1557-8852

Tidskrift

Fler filtreringsmöjligheter
Fler filtreringsmöjligheter

Alla författare

Återställ
till
1 - 40 av 40Sidstorlek: 50
Sortera efter: Utgivningsår
  1. 2018

  2. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free Cu-Labeled Nanoparticles

    Renata Madru, Budassi, M., Benveniste, H., Lee, H., Smith, S. D., Schlyer, D. J., Vaska, P., Linda Knutsson & Sven-Erik Strand, 2018 aug, I : Cancer Biotherapy & Radiopharmaceuticals. 33, 6, s. 213-220 8 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  3. 2015

  4. Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.

    Nilsson, J., Bauden, M., Nilsson, J., Sven-Erik Strand & Elgqvist, J., 2015, I : Cancer Biotherapy & Radiopharmaceuticals. 30, 9, s. 386-394

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  5. 2014

  6. Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.

    Elgström, E., Ljungberg, O., Sophie Eriksson, Anders Örbom, Sven-Erik Strand, Ohlsson, T. G., Rune Nilsson & Jan Tennvall, 2014, I : Cancer Biotherapy & Radiopharmaceuticals. 29, 4, s. 143-152

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  7. Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model.

    Sophie Eriksson, Elgström, E., Bäck, T., Ohlsson, T. G., Jensen, H., Rune Nilsson, Lindegren, S. & Jan Tennvall, 2014, I : Cancer Biotherapy & Radiopharmaceuticals. 29, 6, s. 238-246

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  8. 2012

  10. Repeated Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.

    Sophie Eriksson, Ohlsson, T. G., Rune Nilsson & Jan Tennvall, 2012, I : Cancer Biotherapy & Radiopharmaceuticals. 27, 2, s. 134-140

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  12. Treatment with Unlabeled mAb BR96 After Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.

    Sophie Eriksson, Ohlsson, T. G., Rune Nilsson & Tennvall, J., 2012, I : Cancer Biotherapy & Radiopharmaceuticals. 27, 3, s. 175-182

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  13. 2009

  14. Development and evaluation of a pharmacokinetic model for prediction of radioimmunotherapy based on pretherapy data.

    Nickel, M., Sven-Erik Strand, Lindén, O., Wingårdh, K., Jan Tennvall & Katarina Sjögreen Gleisner, 2009, I : Cancer Biotherapy & Radiopharmaceuticals. 24, 1, s. 111-121

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  15. Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.

    Bjurberg, M., Henriksson, E., Eva Brun, Lars Ekblad, Ohlsson, T. G., Arne Brun & Kjellén, E., 2009, I : Cancer Biotherapy & Radiopharmaceuticals. 24, 3, s. 327-332

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  16. Glomerular Filtration Rate After Alpha-Radioimmunotherapy with At-211-MX35-F(ab ')(2): A Long-Term Study of Renal Function in Nude Mice

    Back, T., Haraldsson, B., Hultborn, R., Jensen, H., Martin Johansson, Lindegren, S. & Jacobsson, L., 2009, I : Cancer Biotherapy & Radiopharmaceuticals. 24, 6, s. 649-658

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  17. 2008

  18. Evaluation of toxicity-reducing potential of ECAT in combination with drug-conjugated mAb BR96

    Mårtensson, L., Rune Nilsson, Hans Olov Sjögren & Jan Tennvall, 2008, I : Cancer Biotherapy and Radiopharmaceuticals. 23, 4, s. 520-520

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  19. Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.

    Nemecek, ER., Green, DJ., Fischer, DR., Pagel, JM., Lin, Y., Gopal, AK., Durack, LD., Rajendran, JG., Wilbur, DS., Rune Nilsson, Sandberg, B. & Press, OW., 2008, I : Cancer Biotherapy & Radiopharmaceuticals. 23, 2, s. 181-191

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  21. Peptide receptor radionuclide therapy (PRRT) using Lu-177-Dotatate: Early clinical and dosimetric results

    Garkavij, M., Katarina Sjögreen Gleisner, Nickel, M., Ohlsson, T. G., Wingårdh, K. & Jan Tennvall, 2008, I : Cancer Biotherapy and Radiopharmaceuticals. 23, 4, s. 524-525

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  22. Quantitative serial imaging of an I-124 anti-CEA monoclonal antibody in tumor-bearing mice

    Bading, J. R., Horling, M., Williams, L. E., Colcher, D., Raubitschek, A. & Sven-Erik Strand, 2008, I : Cancer Biotherapy & Radiopharmaceuticals. 23, 4, s. 399-409

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  23. 2007

  26. Optimization of energy-window settings for scatter correction in quantitative In-111 imaging: Comparison of measurements and Monte Carlo simulations

    Holstensson, M., Hindorf, C., Michael Ljungberg, Partridge, M. & Flux, G. D., 2007, I : Cancer Biotherapy & Radiopharmaceuticals. 22, 1, s. 136-142

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  27. Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread

    Hindorf, C., Emfietzoglou, D., Lindén, O., Bousis, C., Fotopoulos, A., Kostarelos, K. & Flux, G. D., 2007, I : Cancer Biotherapy & Radiopharmaceuticals. 22, 3, s. 357-366

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  28. 2006

  30. Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin ((191)pt) in wistar rats.

    Norrgren, K., Sjölin, M., Bjorkman, S., Areberg, J., Anders Johnsson, Johansson, L. & Sören Mattsson, 2006, I : Cancer Biotherapy & Radiopharmaceuticals. 21, 5, s. 528-534

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  31. 2005

  33. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.

    Lindén, O., Kurkus, J., Garkavij, M., Cavallin-Ståhl, E., Michael Ljungberg, Rune Nilsson, Ohlsson, T. G., Sandberg, B., Sven-Erik Strand & Jan Tennvall, 2005, I : Cancer Biotherapy & Radiopharmaceuticals. 20, 4, s. 457-466

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  35. Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.

    Hindorf, C., Emfietzoglou, D., Lindén, O., Kostarelos, K. & Sven-Erik Strand, 2005, I : Cancer Biotherapy & Radiopharmaceuticals. 20, 2, s. 224-230

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  36. Population biokinetic modeling of thyroid uptake and retention of radioiodine.

    Areberg, J., Jönsson, H. & Sören Mattsson, 2005, I : Cancer Biotherapy & Radiopharmaceuticals. 20, 1, s. 1-10

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  38. 2004

  39. Absorbed dose distribution in glioma tumors in rat brain after therapeutic intratumoral injection of 201Tl-chloride.

    Ljunggren, K., Liu, X., Erlandsson, K., Michael Ljungberg, Leif Salford & Sven-Erik Strand, 2004, I : Cancer Biotherapy & Radiopharmaceuticals. 19, 5, s. 562-569

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  40. Blood pharmacokinetics of various mabs labeled with a new tri-chelating reagent for simultaneous conjugation with DOTA and biotin prior to radiolabeling

    Wang, Z., Mårtensson, L., Rune Nilsson, Pär-Ola Bendahl, Lindgren, L., Ohlsson, T. G., Sjögren, H. O., Sven-Erik Strand & Jan Tennvall, 2004, I : Cancer Biotherapy and Radiopharmaceuticals. 19, 4, s. 540-541

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  41. 2003

  43. Accuracy of the quantification of organ activity from planar gamma camera images

    Norrgren, K., Svegborn, SL., Areberg, J. & Sören Mattsson, 2003, I : Cancer Biotherapy & Radiopharmaceuticals. 18, 1, s. 125-131

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  44. Biokinetics of iodide in man: Refinement of current ICRP dosimetry models

    Johansson, L., Sigrid Leide Svegborn, Sören Mattsson & Nosslin, B., 2003, I : Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 445-450

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  45. Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.

    Wang, Z., Garkavij, M., Ohlsson, T. G., Sven-Erik Strand, Hans Olov Sjögren & Jan Tennvall, 2003, I : Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 365-375

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  46. Calibration of a radioactive ink-based stack phantom and its applications in nuclear medicine.

    El-Ali, H., Michael Ljungberg, Sven-Erik Strand, Palmer, J., Malmgren, L. & Nilsson, J., 2003, I : Cancer Biotherapy & Radiopharmaceuticals. 18, 2, s. 201-207

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  49. Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism.

    Jönsson, H. & Sören Mattsson, 2003, I : Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 473-479

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  50. 1994

  51. Extracorporeal immunoadsorption of 125I-labeled monoclonal antibody L6.

    Norrgren, K., Garkavij, M., Lars, L., Rune Nilsson, Sven-Erik Strand, Jan Tennvall & Hans Olov Sjögren, 1994, I : Antibody, immunoconjugates, and radiopharmaceuticals. 7, s. 29-42

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  52. 1991